This was the year when cannabis stocks were supposed to take off. Not so. And a Morrisville-based firm involved in medical marijuana research is among the companies taking a hit.
Read More
The U.S. government will spend $3 million to find out if marijuana can relieve pain, but none of the money will be used to study the part of the plant that gets people high. Among the recipients in RTI International.
Read More
US Surgeon General Dr. Jerome Adams has a warning for pregnant women and teens when it comes to weed. “No amount of marijuana use during pregnancy or adolescence is safe,” he says.
Read More
The Drug Enforcement Administration is moving forward on a 2016 policy change to allow more entities to grow cannabis for federally approved research. Industry advocates claim such a move would be a boon to not only science but also national legalization efforts — if, that is, the DEA is really going to follow through on what it’s saying.
Read More
Jay-Z joins Joe Montana, Snoop Dogg, Whoopi Goldberg, Willie Nelson, Martha Stewart as part of a growing list of celebrities who have jumped into the cannabis business in recent years as a number of states have legalized marijuana in some form.
Read More
William “Beau” Wrigley Jr. believes he can emulate the success of his family’s old chewing gum empire in the cannabis industry.
Read More
Recent incidents show how businesses remain uncomfortable dealing with hemp — and, specifically, hemp-derived extracts rich in the non-psychoactive cannabis compound cannabidiol (CBD) — even though the plant gained more legal footing late last year. CNN explains.
Read More
Cannabis-related products have flooded the market, making health claims about pain relief, immune function and anxiety and depression. On Friday, the US Food and Drug Administration is holding its first hearing to assess the safety and efficacy of these CBD products.
Read More
Invest in weed, you only live once! That’s the tag line of the newest cannabis ETF on the block. The AdvisorShares Pure Cannabis ETF, with the ticker YOLO, made its market debut last week. It is the second weed-focused exchange traded fund on the market.
Read More
